Johnson & Johnson

JNJ · NYSE · USD

262,51 $Variation par rapport à la clôture précédente: −0,84 %Variation absolue: −2,23 $

Clôture · 1 octobre 2026

Profil de la société

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Drug Manufacturers - General
Siège
One Johnson & Johnson Plaza, 08933, New Brunswick
Salariés
138 200
Directeur général
Joaquin Duato
Année de création
1886
Exercice fiscal
January - December
Cotation
JNJ · NYSE
Devise
USD
ISIN
US4781601046
Site web
jnj.com